Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
NCT07209033

FlexiOss® - Efficacy, Safety and Long-term (Radiological and Clinical) Outcomes During Comprehensive Care Continuum of Implanted Biocomposite for Bone Regeneration.

Led by Medical Inventi S.A. · Updated on 2026-02-12

80

Participants Needed

2

Research Sites

157 weeks

Total Duration

On this page

Sponsors

M

Medical Inventi S.A.

Lead Sponsor

K

KCRI

Collaborating Sponsor

AI-Summary

What this Trial Is About

The aim of this clinical study is to evaluate the efficacy, safety and long-term (radiological and clinical) outcomes during comprehensive care continuum of implanted biocomposite for bone regeneration FlexiOss® compared to the current standard of care in patients with primary acute trauma bone defects. The efficacy, safety and long-term (radiological and clinical) evaluation will be assessed during follow up visits at 2, 6 weeks, 3, 6, 12 and 24 months.

CONDITIONS

Official Title

FlexiOss® - Efficacy, Safety and Long-term (Radiological and Clinical) Outcomes During Comprehensive Care Continuum of Implanted Biocomposite for Bone Regeneration.

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 75 years
  • Signed informed consent and willingness to participate in follow-up visits
  • Existing acute primary bone defect in long bones of the lower extremity or bones of the foot
  • Scheduled for an orthopedic procedure using bone substitute material
Not Eligible

You will not qualify if you...

  • Alcohol dependence syndrome or substance abuse within the past year
  • Pregnancy or breastfeeding
  • Participation in another clinical trial
  • Unstable mental condition or psychiatric disease
  • Severe degenerative or metabolic bone disease affecting healing
  • Allergy or hypersensitivity to FlexiOss4 components
  • Active cancer or undergoing cancer treatment
  • Contraindications to computed tomography angiography (e.g., allergy to contrast agents, impaired kidney function)
  • Severe comorbidities posing risk during surgery or rehabilitation
  • Any condition preventing implantation of FlexiOss4

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Klinika Chirurgii Urazowej i Ortopedii 5 Wojskowy Szpital Kliniczny z Polikliniką SPZOZ

Krakow, Poland, 30-901

Actively Recruiting

2

Klinika Chirurgii Urazowej Narządu Ruchu i Ortopedii CMKP Samodzielny Publiczny Szpital Kliniczny im. prof. Adama Grucy Centrum Medycznego Kształcenia Podyplomowego

Otwock, Poland, 05-400

Actively Recruiting

Loading map...

Research Team

A

Anna Kasprzak-Czelej, PhD

CONTACT

B

Biuro Medical Inventi

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here